Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb EBITDA Margin 2010-2025 | BMY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bristol Myers Squibb (BMY) over the last 10 years. The current EBITDA margin for Bristol Myers Squibb as of March 31, 2025 is .
  
Bristol Myers Squibb EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $47.64B $14.19B 29.78%
2024-12-31 $48.30B $1.22B 2.53%
2024-09-30 $47.44B $3.30B 6.97%
2024-06-30 $46.51B $3.61B 7.76%
2024-03-31 $45.53B $4.02B 8.82%
2023-12-31 $45.01B $18.20B 40.44%
2023-09-30 $44.94B $18.44B 41.04%
2023-06-30 $45.19B $18.67B 41.31%
2023-03-31 $45.85B $18.92B 41.26%
2022-12-31 $46.16B $17.99B 38.97%
2022-09-30 $46.74B $18.05B 38.61%
2022-06-30 $47.14B $18.13B 38.46%
2022-03-31 $46.96B $17.86B 38.03%
2021-12-31 $46.39B $18.78B 40.50%
2021-09-30 $45.47B $6.59B 14.48%
2021-06-30 $44.38B $6.61B 14.90%
2021-03-31 $42.81B $6.53B 15.26%
2020-12-31 $42.52B $3.51B 8.25%
2020-09-30 $39.40B $12.38B 31.42%
2020-06-30 $34.86B $8.99B 25.77%
2020-03-31 $31.01B $6.75B 21.75%
2019-12-31 $26.15B $6.72B 25.71%
2019-09-30 $24.17B $7.29B 30.16%
2019-06-30 $23.86B $8.10B 33.96%
2019-03-31 $23.29B $6.83B 29.34%
2018-12-31 $22.56B $6.61B 29.28%
2018-09-30 $22.04B $5.82B 26.42%
2018-06-30 $21.60B $4.86B 22.51%
2018-03-31 $21.04B $5.69B 27.06%
2017-12-31 $20.78B $5.92B 28.49%
2017-09-30 $20.57B $6.23B 30.30%
2017-06-30 $20.24B $6.53B 32.25%
2017-03-31 $19.97B $6.73B 33.68%
2016-12-31 $19.43B $6.30B 32.41%
2016-09-30 $18.47B $4.76B 25.74%
2016-06-30 $17.62B $4.18B 23.74%
2016-03-31 $16.91B $2.62B 15.50%
2015-12-31 $16.56B $2.45B 14.81%
2015-09-30 $16.53B $2.83B 17.12%
2015-06-30 $16.38B $2.86B 17.44%
2015-03-31 $16.11B $3.20B 19.85%
2014-12-31 $15.88B $2.85B 17.94%
2014-09-30 $16.06B $3.86B 24.00%
2014-06-30 $16.21B $3.73B 23.03%
2014-03-31 $16.37B $3.97B 24.25%
2013-12-31 $16.39B $3.65B 22.30%
2013-09-30 $16.14B $3.61B 22.36%
2013-06-30 $15.81B $3.38B 21.36%
2013-03-31 $16.20B $3.86B 23.85%
2012-12-31 $17.62B $5.14B 29.19%
2012-09-30 $18.88B $6.00B 31.78%
2012-06-30 $20.49B $7.09B 34.59%
2012-03-31 $21.48B $7.86B 36.57%
2011-12-31 $21.24B $7.61B 35.82%
2011-09-30 $20.90B $7.40B 35.41%
2011-06-30 $20.35B $7.30B 35.85%
2011-03-31 $19.69B $7.04B 35.78%
2010-12-31 $19.48B $6.68B 34.27%
2010-09-30 $19.41B $6.46B 33.28%
2010-06-30 $19.40B $6.37B 32.83%
2010-03-31 $19.29B $6.24B 32.35%
2009-12-31 $18.81B $6.03B 32.04%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $94.489B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $218.085B 16.28
Amgen (AMGN) United States $157.284B 14.09
Gilead Sciences (GILD) United States $135.663B 14.09
Vertex Pharmaceuticals (VRTX) United States $119.205B 0.00
CSL (CSLLY) Australia $78.820B 0.00
GSK (GSK) United Kingdom $77.431B 9.27
Regeneron Pharmaceuticals (REGN) United States $59.161B 14.36
Alnylam Pharmaceuticals (ALNY) United States $40.566B 0.00
Argenex SE (ARGX) Netherlands $34.025B 92.66
BioNTech SE (BNTX) Germany $26.599B 0.00
Royalty Pharma (RPRX) United States $20.527B 8.67
Insmed (INSM) United States $19.516B 0.00
Biogen (BIIB) United States $18.682B 8.06
Illumina (ILMN) United States $15.379B 29.17
Genmab (GNMSF) Denmark $14.203B 14.52
Genmab (GMAB) Denmark $13.569B 15.22
Incyte (INCY) United States $13.211B 100.37
Moderna (MRNA) United States $12.213B 0.00
Exelixis (EXEL) United States $12.016B 20.40
BioMarin Pharmaceutical (BMRN) United States $10.858B 17.64
Ascendis Pharma (ASND) Denmark $10.683B 0.00
QIAGEN (QGEN) Netherlands $10.548B 20.52
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $9.996B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.919B 0.00
Blueprint Medicines (BPMC) United States $8.354B 0.00
Bio-Techne Corp (TECH) United States $8.061B 30.07
Roivant Sciences (ROIV) United Kingdom $7.723B 0.00
Legend Biotech (LEGN) United States $7.275B 0.00
Revolution Medicines (RVMD) United States $7.043B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Halozyme Therapeutics (HALO) United States $6.974B 13.35
Anbio Biotechnology (NNNN) Germany $6.871B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.795B 6.67
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.775B 0.00
Repligen (RGEN) United States $6.635B 74.28
TG Therapeutics (TGTX) United States $6.026B 158.17
Guardant Health (GH) United States $5.958B 0.00
Nuvalent (NUVL) United States $5.957B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.685B 0.00
Axsome Therapeutics (AXSM) United States $5.422B 0.00
Telix Pharmaceuticals (TLX) Australia $5.255B 0.00
Alkermes (ALKS) Ireland $4.757B 12.77
CRISPR Therapeutics AG (CRSP) Switzerland $4.554B 0.00
Vaxcyte (PCVX) United States $4.551B 0.00
Cytokinetics (CYTK) United States $4.539B 0.00
Metsera (MTSR) United States $4.515B 0.00
ADMA Biologics Inc (ADMA) United States $4.292B 32.11
Krystal Biotech (KRYS) United States $4.269B 32.90
Akero Therapeutics (AKRO) United States $4.126B 0.00
Zealand Pharma (ZLDPF) Denmark $4.016B 0.00
Zai Lab (ZLAB) China $3.909B 0.00
Avidity Biosciences (RNA) United States $3.820B 0.00
Merus (MRUS) Netherlands $3.806B 0.00
PTC Therapeutics (PTCT) United States $3.785B 6.59
Arcellx (ACLX) United States $3.756B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.684B 32.37
Scholar Rock Holding (SRRK) United States $3.680B 0.00
Viking Therapeutics (VKTX) United States $3.448B 0.00
Protagonist Therapeutics (PTGX) United States $3.429B 73.76
Ascentage Pharma Group - (AAPG) China $3.203B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.179B 0.00
Immunovant (IMVT) United States $2.992B 0.00
Kymera Therapeutics (KYMR) United States $2.925B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.888B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.575B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.572B 0.00
Alvotech (ALVO) Luxembourg $2.535B 14.50
Arrowhead Pharmaceuticals (ARWR) United States $2.435B 0.00
Apellis Pharmaceuticals (APLS) United States $2.432B 0.00
ImmunityBio (IBRX) United States $2.418B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.416B 0.00
Ligand Pharmaceuticals (LGND) United States $2.398B 0.00
Agios Pharmaceuticals (AGIO) United States $2.270B 0.00
Bavarian Nordic (BVNRY) Denmark $2.197B 11.61
Twist Bioscience (TWST) United States $2.179B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.122B 0.00
Denali Therapeutics (DNLI) United States $2.059B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.050B 0.00
Belite Bio (BLTE) United States $2.016B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.001B 13.30
Beam Therapeutics (BEAM) United States $1.969B 0.00
Disc Medicine (IRON) United States $1.949B 0.00
CG Oncology (CGON) United States $1.902B 0.00
IDEAYA Biosciences (IDYA) United States $1.877B 0.00
NovoCure (NVCR) Jersey $1.872B 0.00
Vericel (VCEL) United States $1.868B 1236.67
Arcutis Biotherapeutics (ARQT) United States $1.836B 0.00
Amicus Therapeutics (FOLD) United States $1.820B 197.00
Sarepta Therapeutics (SRPT) United States $1.790B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.766B 0.00
Apogee Therapeutics (APGE) United States $1.710B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.705B 0.00
Certara (CERT) United States $1.689B 31.55
Adaptive Biotechnologies (ADPT) United States $1.680B 0.00
89BIO (ETNB) United States $1.534B 0.00
Janux Therapeutics (JANX) United States $1.524B 0.00
Celldex Therapeutics (CLDX) United States $1.517B 0.00
Vera Therapeutics (VERA) United States $1.480B 0.00
Travere Therapeutics (TVTX) United States $1.455B 0.00
Edgewise Therapeutics (EWTX) United States $1.408B 0.00
Mesoblast (MESO) Australia $1.400B 0.00
ANI Pharmaceuticals (ANIP) United States $1.386B 14.29
GRAIL (GRAL) United States $1.386B 0.00
Biohaven (BHVN) United States $1.354B 0.00
Viridian Therapeutics (VRDN) United States $1.327B 0.00
Cogent Biosciences (COGT) United States $1.309B 0.00
Dynavax Technologies (DVAX) United States $1.254B 74.57
Liquidia Technologies (LQDA) United States $1.240B 0.00
CureVac (CVAC) Germany $1.214B 5.88
Pharvaris (PHVS) Netherlands $1.202B 0.00
WAVE Life Sciences (WVE) Singapore $1.199B 0.00
Intellia Therapeutics (NTLA) United States $1.189B 0.00
AbCellera Biologics (ABCL) Canada $1.176B 0.00
MannKind (MNKD) United States $1.170B 24.06
Novavax (NVAX) United States $1.114B 2.60
Structure Therapeutics (GPCR) United States $1.103B 0.00
Praxis Precision Medicines (PRAX) United States $1.057B 0.00
Pacira BioSciences (PCRX) United States $1.052B 10.01
Cidara Therapeutics (CDTX) United States $1.038B 0.00
Arcus Biosciences (RCUS) United States $0.956B 0.00
Replimune (REPL) United States $0.956B 0.00
Mineralys Therapeutics (MLYS) United States $0.953B 0.00
Sana Biotechnology (SANA) United States $0.942B 0.00
Oric Pharmaceuticals (ORIC) United States $0.936B 0.00
MiMedx (MDXG) United States $0.935B 22.61
Nurix Therapeutics (NRIX) United States $0.929B 0.00
Anavex Life Sciences (AVXL) United States $0.928B 0.00
Spyre Therapeutics (SYRE) United States $0.923B 0.00
LENZ Therapeutics (LENZ) United States $0.922B 0.00
Zymeworks (ZYME) United States $0.898B 0.00
Jyong Biotech (MENS) Taiwan $0.890B 0.00
NeoGenomics (NEO) United States $0.888B 0.00
Niagen Bioscience (NAGE) United States $0.873B 123.11
BGM Group (BGM) China $0.865B 0.00
GH Research (GHRS) Ireland $0.832B 0.00
Sionna Therapeutics (SION) United States $0.818B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Trevi Therapeutics (TRVI) United States $0.805B 0.00
Geron (GERN) United States $0.803B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.793B 0.00
AnaptysBio (ANAB) United States $0.782B 0.00
Oculis Holding AG (OCS) Switzerland $0.781B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
CorMedix Inc (CRMD) United States $0.771B 51.68
UniQure (QURE) Netherlands $0.765B 0.00
ArriVent BioPharma (AVBP) United States $0.740B 0.00
Vir Biotechnology (VIR) United States $0.733B 0.00
Immunome (IMNM) United States $0.731B 0.00
Nuvation Bio (NUVB) United States $0.725B 0.00
Immatics (IMTX) Germany $0.724B 0.00
Maze Therapeutics (MAZE) United States $0.701B 0.00
Pharming Group (PHAR) Netherlands $0.692B 0.00
MeiraGTx Holdings (MGTX) United States $0.689B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.677B 0.00
Gyre Therapeutics (GYRE) United States $0.671B 179.00
Day One Biopharmaceuticals (DAWN) United States $0.666B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.663B 0.00
Iovance Biotherapeutics (IOVA) United States $0.648B 0.00
Urogen Pharma (URGN) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.642B 14.87
Tango Therapeutics (TNGX) United States $0.641B 0.00
Dianthus Therapeutics (DNTH) United States $0.612B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.610B 0.00
Arbutus Biopharma (ABUS) United States $0.599B 0.00
Upstream Bio (UPB) United States $0.599B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.596B 0.00
Keros Therapeutics (KROS) United States $0.579B 0.00
Prime Medicine (PRME) United States $0.577B 0.00
Sage Therapeutics (SAGE) United States $0.574B 0.00
Abivax SA (ABVX) France $0.562B 0.00
Bicara Therapeutics (BCAX) United States $0.558B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.552B 0.00
Precigen (PGEN) United States $0.546B 0.00
Castle Biosciences (CSTL) United States $0.545B 37.00
Arvinas (ARVN) United States $0.540B 0.00
Tyra Biosciences (TYRA) United States $0.538B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.532B 0.00
Kura Oncology (KURA) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Rapport Therapeutics (RAPP) United States $0.525B 0.00
Celcuity (CELC) United States $0.522B 0.00
Septerna (SEPN) United States $0.520B 0.00
Zenas BioPharma (ZBIO) United States $0.517B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
ATyr Pharma (ATYR) United States $0.501B 0.00
Myriad Genetics (MYGN) United States $0.461B 0.00
MBX Biosciences (MBX) United States $0.448B 0.00
Terns Pharmaceuticals (TERN) United States $0.441B 0.00
Cullinan Therapeutics (CGEM) United States $0.440B 0.00
Rezolute (RZLT) United States $0.437B 0.00
Kamada (KMDA) Israel $0.435B 26.07
PureTech Health (PRTC) United States $0.431B 0.00
Fortrea Holdings (FTRE) United States $0.427B 11.80
Fulcrum Therapeutics (FULC) United States $0.423B 0.00
Solid Biosciences (SLDB) United States $0.418B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.416B 0.00
REGENXBIO (RGNX) United States $0.413B 0.00
Compass Therapeutics (CMPX) United States $0.412B 0.00
Cytek Biosciences (CTKB) United States $0.412B 0.00
Tectonic Therapeutic (TECX) United States $0.400B 0.00
Erasca (ERAS) United States $0.399B 0.00
ITeos Therapeutics (ITOS) United States $0.395B 0.00
Eton Pharmaceuticals (ETON) United States $0.387B 0.00
Northwest Biotherapeutics (NWBO) United States $0.385B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Emergent Biosolutions (EBS) United States $0.376B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.357B 0.00
Astria Therapeutics (ATXS) United States $0.356B 0.00
Humacyte (HUMA) United States $0.354B 0.00
Cartesian Therapeutics (RNAC) United States $0.352B 0.00
Prothena (PRTA) Ireland $0.335B 0.00
Inhibrx Biosciences (INBX) United States $0.332B 0.20
Aura Biosciences (AURA) United States $0.330B 0.00
Gossamer Bio (GOSS) United States $0.330B 0.00
Absci (ABSI) United States $0.328B 0.00
Amarin (AMRN) Ireland $0.327B 0.00
Benitec Biopharma (BNTC) United States $0.327B 0.00
Foghorn Therapeutics (FHTX) United States $0.323B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.322B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.322B 65.38
Inventiva S.A (IVA) France $0.319B 0.00
XOMA Royalty (XOMA) United States $0.314B 0.00
Olema Pharmaceuticals (OLMA) United States $0.314B 0.00
Candel Therapeutics (CADL) United States $0.313B 0.00
Ocugen (OCGN) United States $0.312B 0.00
Palvella Therapeutics (PVLA) United States $0.306B 0.00
Neurogene (NGNE) United States $0.306B 0.00
Atea Pharmaceuticals (AVIR) United States $0.306B 0.00
Abeona Therapeutics (ABEO) United States $0.304B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.300B 0.00
Sagimet Biosciences (SGMT) United States $0.291B 0.00
Lifecore Biomedical (LFCR) United States $0.285B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.284B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.281B 0.00
Vor Biopharma (VOR) $0.281B 0.00
DBV Technologies S.A (DBVT) France $0.278B 0.00
Annexon (ANNX) United States $0.274B 0.00
Cardiff Oncology (CRDF) United States $0.274B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.272B 0.00
Allogene Therapeutics (ALLO) United States $0.271B 0.00
Verastem (VSTM) United States $0.269B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.262B 0.00
Kodiak Sciences (KOD) United States $0.254B 0.00
Aardvark Therapeutics (AARD) United States $0.252B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Tvardi Therapeutics (TVRD) United States $0.244B 0.00
Monopar Therapeutics (MNPR) United States $0.243B 0.00
Entrada Therapeutics (TRDA) United States $0.242B 7.86
Adherex Technologies (FENC) United States $0.240B 0.00
Prima BioMed (IMMP) Australia $0.238B 0.00
Alpha Teknova (TKNO) United States $0.235B 0.00
Neumora Therapeutics (NMRA) United States $0.235B 0.00
Codexis (CDXS) United States $0.233B 0.00
ScPharmaceuticals (SCPH) United States $0.232B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.231B 0.00
Editas Medicine (EDIT) United States $0.230B 0.00
Crescent Biopharma (CBIO) United States $0.230B 0.00
MaxCyte (MXCT) United States $0.225B 0.00
Design Therapeutics (DSGN) United States $0.223B 0.00
Semper Paratus Acquisition (TVGN) United States $0.221B 0.00
Adocia (ADOCY) France $0.216B 0.00
Ventyx Biosciences (VTYX) United States $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.213B 0.00
AC Immune (ACIU) Switzerland $0.206B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.194B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 5.00
Y-mAbs Therapeutics (YMAB) United States $0.191B 0.00
Alumis (ALMS) United States $0.190B 0.00
SELLAS Life Sciences (SLS) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
DiaMedica Therapeutics (DMAC) United States $0.184B 0.00
EnGene Holdings (ENGN) Canada $0.179B 0.00
Rapt Therapeutics (RAPT) United States $0.175B 0.00
Nuvectis Pharma (NVCT) United States $0.173B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.172B 0.00
Puma Biotechnology (PBYI) United States $0.172B 4.49
Bright Minds Biosciences (DRUG) United States $0.172B 0.00
I-Mab (IMAB) United States $0.171B 0.00
Agenus (AGEN) United States $0.171B 0.00
Voyager Therapeutics (VYGR) United States $0.170B 0.00
Black Diamond Therapeutics (BDTX) United States $0.168B 49.17
BioStem Technologies (BSEM) $0.167B 6.80
Alpha Cognition (ACOG) Canada $0.167B 0.00
Kyverna Therapeutics (KYTX) United States $0.165B 0.00
Innate Pharma S.A (IPHA) France $0.163B 0.00
BioAge Labs (BIOA) United States $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.158B 0.00
Instil Bio (TIL) United States $0.157B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.155B 0.00
Alector (ALEC) United States $0.155B 0.00
Immuneering (IMRX) United States $0.150B 0.00
C4 Therapeutics (CCCC) United States $0.150B 0.00
Caribou Biosciences (CRBU) United States $0.150B 0.00
Elicio Therapeutics (ELTX) United States $0.147B 0.00
Theratechnologies (THTX) Canada $0.144B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
Compugen (CGEN) Israel $0.141B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.141B 0.00
Spero Therapeutics (SPRO) United States $0.139B 0.00
Greenwich LifeSciences (GLSI) United States $0.135B 0.00
23andMe Holding (MEHCQ) United States $0.134B 0.00
Fate Therapeutics (FATE) United States $0.130B 0.00
Nkarta (NKTX) United States $0.129B 0.00
Seres Therapeutics (MCRB) United States $0.128B 0.00
Seer (SEER) United States $0.124B 0.00
BioHarvest Sciences (BHST) Canada $0.118B 0.00
Cellectis S.A (CLLS) France $0.117B 0.00
Actuate Therapeutics (ACTU) United States $0.117B 0.00
Genelux (GNLX) United States $0.116B 0.00
Skye Bioscience (SKYE) United States $0.116B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
IO Biotech (IOBT) Denmark $0.112B 0.00
Sangamo Therapeutics (SGMO) United States $0.112B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.112B 0.00
MiNK Therapeutics (INKT) United States $0.112B 0.00
Citius Oncology (CTOR) United States $0.110B 0.00
HilleVax (HLVX) United States $0.107B 0.00
Oncolytics Biotech (ONCY) Canada $0.107B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.101B 0.00
TuHURA Biosciences (HURA) United States $0.100B 0.00
TScan Therapeutics (TCRX) United States $0.100B 0.00
Coherus Oncology (CHRS) United States $0.098B 0.00
Contineum Therapeutics (CTNM) United States $0.098B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
OKYO Pharma (OKYO) $0.093B 0.00
Climb Bio (CLYM) United States $0.093B 0.00
Whitehawk Therapeutics (WHWK) United States $0.091B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
Adagene (ADAG) China $0.090B 0.00
Zura Bio (ZURA) United States $0.089B 0.00
Entera Bio (ENTX) Israel $0.085B 0.00
Pliant Therapeutics (PLRX) United States $0.085B 0.00
XBiotech (XBIT) United States $0.084B 0.00
EXoZymes (EXOZ) United States $0.083B 0.00
Cabaletta Bio (CABA) United States $0.083B 0.00
Invivyd (IVVD) United States $0.082B 0.00
Elutia (ELUT) United States $0.081B 0.00
Connect Biopharma Holdings (CNTB) United States $0.081B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
TELA Bio (TELA) United States $0.080B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.079B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.079B 0.00
Quince Therapeutics (QNCX) United States $0.079B 0.00
Immix Biopharma (IMMX) United States $0.077B 0.00
Oncobiologics (OTLK) United States $0.076B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
Ikena Oncology (IKNA) United States $0.069B 0.00
Biomea Fusion (BMEA) United States $0.067B 0.00
Opus Genetics (IRD) United States $0.066B 0.00
VistaGen Therapeutics (VTGN) United States $0.066B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Sutro Biopharma (STRO) United States $0.063B 0.00
Adicet Bio (ACET) United States $0.063B 0.00
CervoMed (CRVO) United States $0.063B 0.00
Forte Biosciences (FBRX) United States $0.062B 0.00
Repare Therapeutics (RPTX) Canada $0.061B 0.00
ABVC BioPharma (ABVC) United States $0.061B 0.00
MediciNova (MNOV) United States $0.060B 0.00
Applied Therapeutics (APLT) United States $0.060B 0.00
Celularity (CELU) United States $0.059B 0.00
Werewolf Therapeutics (HOWL) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.057B 0.00
Quantum Biopharma (QNTM) Canada $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Adverum Biotechnologies (ADVM) United States $0.055B 0.00
InflaRx (IFRX) Germany $0.055B 0.00
VTv Therapeutics (VTVT) United States $0.054B 0.00
PDS Biotechnology (PDSB) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.052B 0.00
Aligos Therapeutics (ALGS) United States $0.052B 0.00
Artiva Biotherapeutics (ARTV) United States $0.052B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Jasper Therapeutics (JSPR) United States $0.050B 0.00
Precision BioSciences (DTIL) United States $0.049B 0.00
Senti Biosciences (SNTI) United States $0.049B 0.00
INmune Bio (INMB) United States $0.049B 0.00
Renovaro (RENB) United States $0.048B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Inovio Pharmaceuticals (INO) United States $0.048B 0.00
Scilex Holding (SCLX) United States $0.047B 0.00
Kalaris Therapeutics (KLRS) United States $0.045B 0.00
Grace Therapeutics (GRCE) Canada $0.044B 0.00
Exicure (XCUR) United States $0.043B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Mersana Therapeutics (MRSN) United States $0.041B 0.00
PepGen (PEPG) United States $0.041B 0.00
Lantern Pharma (LTRN) United States $0.041B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
Alterity Therapeutics - (ATHE) Australia $0.040B 0.00
Pluri (PLUR) Israel $0.039B 0.00
Shattuck Labs (STTK) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.037B 0.00
KALA BIO (KALA) United States $0.035B 0.00
Cognition Therapeutics (CGTX) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.034B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.031B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
Clene (CLNN) United States $0.031B 0.00
Femasys (FEMY) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
CAMP4 Therapeutics (CAMP) United States $0.029B 0.00
CalciMedica (CALC) United States $0.029B 0.00
Generation Bio (GBIO) United States $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
FibroBiologics (FBLG) United States $0.028B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.027B 0.00
Rani Therapeutics Holdings (RANI) United States $0.027B 0.00
Ovid Therapeutics (OVID) United States $0.026B 0.00
Q32 Bio (QTTB) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.022B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.019B 0.00
Curis (CRIS) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
Passage Bio (PASG) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Advanced Biomed (ADVB) United States $0.017B 0.00
Rallybio (RLYB) United States $0.017B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Promis Neurosciences (PMN) Canada $0.014B 0.00
HOOKIPA Pharma (HOOK) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Synaptogenix (TAOX) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.010B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Imunon (IMNN) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Artelo Biosciences (ARTL) United States $0.009B 0.00
X4 Pharmaceuticals (XFOR) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00